Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma

PURPOSE: Immunogenic cell death (ICD) is a cell death modality that plays a vital role in anticancer therapy. In this study, we investigated whether lenvatinib induces ICD in hepatocellular carcinoma and how it affects cancer cell behavior. PATIENTS AND METHODS: Hepatoma cells were treated with 0.5...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Cheng, Yang, Zhang-Fu, Sun, Bao-Ye, Yi, Yong, Wang, Zheng, Zhou, Jian, Fan, Jia, Gan, Wei, Ren, Ning, Qiu, Shuang-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149778/
https://www.ncbi.nlm.nih.gov/pubmed/37138764
http://dx.doi.org/10.2147/JHC.S401639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149778/
https://www.ncbi.nlm.nih.gov/pubmed/37138764
http://dx.doi.org/10.2147/JHC.S401639

Ejemplares similares